RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of ABBV
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

Green day on Thursday for AbbVie
(Updated on Mar 28, 2024)

Buy candidate since Mar 21, 2024 Gain 2.59% PDF

The AbbVie stock price gained 0.97% on the last trading day (Thursday, 28th Mar 2024), rising from $180.35 to $182.10. It has now gained 6 days in a row. It is not often that stocks manage to gain so many days in a row, and falls for a day or two should be expected. During the last trading day the stock fluctuated 1.10% from a day low at $180.30 to a day high of $182.29. The price has risen in 8 of the last 10 days and is up by 0.5% over the past 2 weeks. Volume fell on the last day by -2 million shares and in total, 3 million shares were bought and sold for approximately $561.14 million. You should take into consideration that falling volume on higher prices causes divergence and may be an early warning about possible changes over the next couple of days.

The stock lies in the middle of a narrow and strong rising trend in the short term and a further rise within the trend is signaled. Given the current short-term trend, the stock is expected to rise 14.57% during the next 3 months and, with a 90% probability hold a price between $204.60 and $212.01 at the end of this 3-month period.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

ABBV Signals & Forecast

The AbbVie stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $178.91 and $177.91. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, March 20, 2024, and so far it has risen 3.31%. Further rise is indicated until a new top pivot has been found. Volume fell during the last trading day despite gaining prices. This causes a divergence between volume and price and it may be an early warning. The stock should be watched closely. Some negative signals were issued as well, and these may have some influence on the near short-term development. Furthermore, there is currently a sell signal from the 3 month Moving Average Convergence Divergence (MACD).

Support, Risk & Stop-loss for AbbVie stock

AbbVie finds support from accumulated volume at $176.27 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

In general the stock tends to have very controlled movements and with good liquidity the risk is considered very low in this stock. During the last day, the stock moved $1.99 between high and low, or 1.10%. For the last week the stock has had daily average volatility of 0.94%.

Since the AbbVie has been rising for 6 days in a row, the risk over the next couple of days has increased. We don't expect a major reaction as the stock is in very good shape technically, and therefore hold a positive evaluation despite the very short term risk.

Our recommended stop-loss: $174.10 (-4.39%) (This stock has low daily movements and this gives low risk. There is a buy signal from a pivot bottom found 6 days ago.)

Trading Expectations (ABBV) For The Upcoming Trading Day Of Monday 1st

For the upcoming trading day on Monday, 1st we expect AbbVie Inc to open at $181.56, and during the day (based on 14 day Average True Range), to move between $179.55 and $184.65, which gives a possible trading interval of +/-$2.55 (+/-1.40%) up or down from last closing price. If AbbVie Inc takes out the full calculated possible swing range there will be an estimated 2.80% move between the lowest and the highest trading price during the day.

With no resistance above and support from accumulated volume @ $176.27, some $5.83 (3.20%) from the current price of $182.10, our system finds the risk reward attractive.

Is AbbVie Inc stock A Buy?

AbbVie holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

Current score: 6.466 Strong Buy Candidate Unchanged

Predicted Opening Price for AbbVie Inc of Monday, April 1, 2024

Fair opening price April 1, 2024 Current price
$181.56 ( 0.295%) $182.10

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Trading levels for ABBV

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 183.55 0.798 %
R2 182.79 0.381 %
R1 182.32 0.123 %
Current price: 182.10
Support S1 180.80 -0.712 %
S2 180.33 -0.97 %
S3 179.57 -1.39 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0 .
R2 0 .
R1 0 .
Current price 182.10
Support S1 176.27 -3.20%
S2 173.29 -4.84%
S3 164.40 -9.72%

ABBV Dividend Payout History


# Declaration Date Ex-Date Pay Date Amount Yield
1 Apr 12, 2024 Apr 12, 2024 May 15, 2024 $1.55 0.85%
2 Oct 27, 2023 Jan 12, 2024 Feb 15, 2024 $1.55 0.88%
3 Sep 08, 2023 Oct 12, 2023 Nov 15, 2023 $1.48 1.08%
4 Jun 22, 2023 Jul 14, 2023 Aug 15, 2023 $1.48 0.97%
5 Jun 22, 2023 Jul 13, 2023 Aug 15, 2023 $1.48 0.97%

FAQ

What is the symbol for AbbVie Stock and on which exchange is it traded?
The symbol for AbbVie is ABBV and it is traded on the NYSE (New York Stock Exchange).

Should I buy or sell AbbVie Stock?
AbbVie holds several positive signals and is within a strong rising trend. As the old saying says, "Let the trend be your friend.'". We therefore consider it to be a good choice at these current levels and we are expecting further gains during the next 3 months.

How to buy AbbVie Stock?
AbbVie Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy AbbVie Stock.

What's the current price of AbbVie Stock?
As of the end of day on the 2024-03-28, the price of an AbbVie (ABBV) share was $182.10.

What is the 52-week high and low for AbbVie Stock?
The 52-week high for AbbVie Stock is $182.89 and the 52-week low is $130.96.

What is the market capitalization of AbbVie Stock?
As of the 2024-03-28, the market capitalization of AbbVie is 321.674B.

When is the next earnings date for AbbVie?
The upcoming earnings date for AbbVie is Apr 25, 2024.
Click to get the best stock tips daily for free!

About AbbVie Inc

AbbVie AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheumatoid arthritis in adult patients; IMBRUVICA to treat adult patients with chronic lymphocytic leukemia ... ABBV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT